Brainomix’s e-Lung shows progression and treatment response in Phase III trial

Phase 3positivee-LungPositive

AI Analysis

Summary

Brainomix's e-Lung demonstrated progression and treatment response in a Phase III trial. The study incorporated AI-based imaging tools into its protocol.

Clinical Trial Data

Phase

Phase III

Primary Endpoint

Met

Outcome Details

Shows progression and treatment response

Importance:5/10

Sentiment:

0.60

Phase IIIAI-based toolsimagingclinical trial

Related Companies

$TRAX $ARNA

Read the original article

Published by Clinical Trials Arena on October 2, 2026 3:15 PM

Read Original